# Combined Intravenous Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Orthopaedic Surgery of the Foot and Ankle

> **NCT04818749** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 120 (actual)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** Saline
- **DRUG:** Dexamethasone 12 mg
- **DRUG:** Dexamethasone 12 mg + dexmedetomidine 1 mcg/kg

## Key facts

- **NCT ID:** NCT04818749
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-02
- **Primary completion:** 2023-04-17
- **Final completion:** 2023-05-17
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818749, "Combined Intravenous Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Orthopaedic Surgery of the Foot and Ankle". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04818749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*